Primary Four Repeat Tauopathies (4RT)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Primary Four Repeat Tauopathies (4RT) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1

NCT02133846

Safety Study of TPI-287 to Treat CBS and PSP

The purpose of this study is to determine the safety and tolerability \[maximum tolerated dose (MTD) within planned dosing range\] of intravenous (IV) infusions…

United States44 participantsStarted 2014-05

Treatment: TPI 287 2 mg/m2, TPI-287 20 mg/m2